Trexquant Investment LP Purchases 364,990 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Trexquant Investment LP grew its position in LifeStance Health Group, Inc. (NASDAQ:LFST) by 111.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 692,037 shares of the company’s stock after acquiring an additional 364,990 shares during the quarter. Trexquant Investment LP’s holdings in LifeStance Health Group were worth $5,100,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the company. Blue Trust Inc. lifted its position in LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after purchasing an additional 2,122 shares during the period. Townsquare Capital LLC acquired a new position in shares of LifeStance Health Group in the 3rd quarter valued at $73,000. R Squared Ltd bought a new position in shares of LifeStance Health Group during the 4th quarter worth about $80,000. Cibc World Markets Corp acquired a new stake in shares of LifeStance Health Group during the 4th quarter valued at about $96,000. Finally, Handelsbanken Fonder AB bought a new stake in LifeStance Health Group in the fourth quarter valued at about $128,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

Insider Transactions at LifeStance Health Group

In related news, insider Lisa K. Miller sold 18,845 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the transaction, the insider now owns 339,810 shares in the company, valued at $2,344,689. This represents a 5.25 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 6.60% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on LFST shares. William Blair restated an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a research note on Monday, December 16th. Finally, Canaccord Genuity Group started coverage on LifeStance Health Group in a research note on Thursday. They set a “buy” rating and a $8.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

LifeStance Health Group Stock Down 1.5 %

NASDAQ LFST opened at $6.64 on Friday. The stock’s 50 day simple moving average is $7.47 and its 200 day simple moving average is $7.34. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. LifeStance Health Group, Inc. has a one year low of $4.64 and a one year high of $8.61. The firm has a market cap of $2.55 billion, a PE ratio of -25.54 and a beta of 1.30.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.